The present invention relates to the use of the alkaloid K252 and its analogues or derivatives to prepare topical drugs for the treatment of disorders characterised by hyperproliferation of keratinocytes

Topical use of tyrosine kinase inhibitors of microbial origin to prevent and treat skin disorders characterised by excesssive cell proliferation / Pincelli, Carlo. - .

Topical use of tyrosine kinase inhibitors of microbial origin to prevent and treat skin disorders characterised by excesssive cell proliferation

PINCELLI, Carlo

Abstract

The present invention relates to the use of the alkaloid K252 and its analogues or derivatives to prepare topical drugs for the treatment of disorders characterised by hyperproliferation of keratinocytes
2005
http://v3.espacenet.com/publicationDetails/biblio?CC=WO&NR=2005014003A1&KC=A1&FT=D&date=20050217&DB=EPODOC&locale=en_EP
CREABILIS THERAPEUTICS S R L [IT]
WO2005014003
K252; hyperproliferation disorders; psoriasis
Also published as:US2006210553EP1653972AU2003250150
Pincelli, Carlo
Altro::Brevetto
285
none
Topical use of tyrosine kinase inhibitors of microbial origin to prevent and treat skin disorders characterised by excesssive cell proliferation / Pincelli, Carlo. - .
1
info:eu-repo/semantics/patent
Brevetto
File in questo prodotto:
Non ci sono file associati a questo prodotto.
Pubblicazioni consigliate

Licenza Creative Commons
I metadati presenti in IRIS UNIMORE sono rilasciati con licenza Creative Commons CC0 1.0 Universal, mentre i file delle pubblicazioni sono rilasciati con licenza Attribuzione 4.0 Internazionale (CC BY 4.0), salvo diversa indicazione.
In caso di violazione di copyright, contattare Supporto Iris

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11380/593345
Citazioni
  • ???jsp.display-item.citation.pmc??? ND
  • Scopus ND
  • ???jsp.display-item.citation.isi??? ND
social impact